DocDollars

Beigene USA, Inc.

MA · United States · Reporting entity ID 100000826832

Total reported 2019–2025
$31.6M
#230 of 2,960 reporting companies — 0% of all reported industry payments
$10.7M in general payments across 36,662 records, plus $20.9M in research funding across 1,794 records.

How it breaks down

General payments $10,671,330
Research funding $20,902,697

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Beigene USA, Inc. reported $31.6M to US doctors and teaching hospitals from 2019 to 2025, ranking #230 of 2,960 reporting companies. 66% of that was research funding and 34% general payments such as consulting, speaking, food and travel. 36,662 general payment records and 1,794 research records were filed.

Common questions about Beigene USA, Inc.

How much has Beigene USA, Inc. paid US doctors?

Beigene USA, Inc. reported $31,574,027 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $10,671,330 in general payments, $20,902,697 in research funding.

How does Beigene USA, Inc. rank among drug and device companies?

It ranks #230 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Beigene USA, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.